HPE appoints former Pfizer CFO Frank D'Amelio to Board of Directors

Hewlett Packard Enterprise Co

Appointment effective January 10, 2023; D'Amelio also joins Audit Committee.
D'Amelio was EVP & CFO of Pfizer; oversaw Global Supply from 2018-2021.
He receives pro-rata portion of annual equity and cash retainer for current board year.
Previously COO/CFO at Lucent Technologies; currently on boards of Humana and Zoetis.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Frank A. D'Amelio

Director

HPE · Hewlett Packard Enterprise Co

Effective: 2023-01-10
Filed: January 10, 2023, 6:59 PM ET

Effective as of January 10, 2023, the Board of Directors (the “Board”) of Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”) has appointed Frank A. D'Amelio, the former Executive Vice President and CFO of Pfizer Inc., a research-based global biopharmaceutical company, to serve as a director of Hewlett Packard Enterprise.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Frank A. D'Amelio was appointed as Director at Hewlett Packard Enterprise Co.

Action: appointed
Role: Director

Exact text from the filing

Effective as of January 10, 2023, the Board of Directors (the “Board”) of Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”) has appointed Frank A. D'Amelio, the former Executive Vice President and CFO of Pfizer Inc., a research-based global biopharmaceutical company, to serve as a director of Hewlett Packard Enterprise.

View on SEC.gov

Hewlett Packard Enterprise Co filing history →

Source: SEC EDGAR

accession 0001645590-23-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.